‌

US Patent 10717728 Potassium channel modulators

Patent 10717728 was granted and assigned to Cadent Therapeutics on July, 2020 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Cadent Therapeutics

Current Assignee

Cadent Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

107177280

Date of Patent

July 21, 2020

Patent Application Number

164312120

Date Filed

June 4, 2019

Patent Citations

‌

US Patent 10351553 Potassium channel modulators

Patent Citations Received

‌

US Patent 11993586 Crystalline forms of potassium channel modulators

Patent Primary Examiner

‌

Jeffrey H Murray

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10717728 Potassium channel modulators

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API